BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 31307125)

  • 1. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.
    Costa RGF; Caro PL; de Matos-Neto EM; Lima JDCC; Radloff K; Alves MJ; Camargo RG; Pessoa AFM; Simoes E; Gama P; Cara DC; da Silva ASF; O Pereira W; Maximiano LF; de Alcântara PSM; Otoch JP; Trinchieri G; Laviano A; Muscaritoli M; Seelaender M
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1116-1127. PubMed ID: 31307125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
    Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients.
    Neto NIP; Murari ASP; Oyama LM; Otoch JP; Alcântara PSM; Tokeshi F; Figuerêdo RG; Alves MJ; Lima JDCC; Matos-Neto EM; Seelaender M; Oller do Nascimento CM
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1101-1108. PubMed ID: 30284380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cachexia causes time-dependent activation of the inflammasome in the liver.
    das Neves RX; Yamashita AS; Riccardi DMR; Köhn-Gaone J; Camargo RG; Neto NI; Caetano D; Gomes SP; Santos FH; Lima JDCC; Batista ML; Rosa-Neto JC; Martins De Alcântara PS; Maximiano LF; Otoch JP; Trinchieri G; Tirnitz-Parker JEE; Seelaender M
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1621-1630. PubMed ID: 37177862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.
    Alves MJ; Figuerêdo RG; Azevedo FF; Cavallaro DA; Neto NI; Lima JD; Matos-Neto E; Radloff K; Riccardi DM; Camargo RG; De Alcântara PS; Otoch JP; Junior ML; Seelaender M
    BMC Cancer; 2017 Mar; 17(1):190. PubMed ID: 28288584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myokines in treatment-naïve patients with cancer-associated cachexia.
    de Castro GS; Correia-Lima J; Simoes E; Orsso CE; Xiao J; Gama LR; Gomes SP; Gonçalves DC; Costa RGF; Radloff K; Lenz U; Taranko AE; Bin FC; Formiga FB; de Godoy LGL; de Souza RP; Nucci LHA; Feitoza M; de Castro CC; Tokeshi F; Alcantara PSM; Otoch JP; Ramos AF; Laviano A; Coletti D; Mazurak VC; Prado CM; Seelaender M
    Clin Nutr; 2021 Apr; 40(4):2443-2455. PubMed ID: 33190987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
    Kasprzak A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib attenuates cachectic events in mice by modulating the expression of vascular endothelial growth factor.
    Xu X; Jiang M; Zhang Y; Bi Y; Han M
    Mol Med Rep; 2015 Jan; 11(1):289-94. PubMed ID: 25333891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2.
    Li X; Holtrop T; Jansen FAC; Olson B; Levasseur P; Zhu X; Poland M; Schalwijk W; Witkamp RF; Marks DL; van Norren K
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3014-3027. PubMed ID: 36303458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer.
    Silvério R; Lira FS; Oyama LM; Oller do Nascimento CM; Otoch JP; Alcântara PSM; Batista ML; Seelaender M
    Lipids Health Dis; 2017 Aug; 16(1):159. PubMed ID: 28830524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation -induced inflammation.
    Gonçalves DC; Lira FS; Yamashita AS; Carnevali Junior LC; Eder R; Laviano A; Seelaender MCL
    Clin Nutr; 2019 Oct; 38(5):2219-2230. PubMed ID: 30322784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.
    Plata-Salamán CR
    Nutrition; 2000 Oct; 16(10):1009-12. PubMed ID: 11054608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages protect against loss of adipose tissue during cancer cachexia.
    Erdem M; Möckel D; Jumpertz S; John C; Fragoulis A; Rudolph I; Wulfmeier J; Springer J; Horn H; Koch M; Lurje G; Lammers T; Olde Damink S; van der Kroft G; Gremse F; Cramer T
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1128-1142. PubMed ID: 31318182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
    Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.
    Tsoli M; Schweiger M; Vanniasinghe AS; Painter A; Zechner R; Clarke S; Robertson G
    PLoS One; 2014; 9(3):e92966. PubMed ID: 24667661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
    Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
    Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-induced cholestasis in cancer cachexia.
    Thibaut MM; Sboarina M; Roumain M; Pötgens SA; Neyrinck AM; Destrée F; Gillard J; Leclercq IA; Dachy G; Demoulin JB; Tailleux A; Lestavel S; Rastelli M; Everard A; Cani PD; Porporato PE; Loumaye A; Thissen JP; Muccioli GG; Delzenne NM; Bindels LB
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):70-90. PubMed ID: 33350058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review examining the relationship between cytokines and cachexia in incurable cancer.
    Paval DR; Patton R; McDonald J; Skipworth RJE; Gallagher IJ; Laird BJ;
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):824-838. PubMed ID: 35080147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.